Plasma concentrations of efavirenz, darunavir/ritonavir and raltegravir in HIV-HCV-coinfected patients without liver cirrhosis in comparison with HIV-monoinfected patients.
about
Liver Toxicity of Current Antiretroviral Regimens in HIV-Infected Patients with Chronic Viral Hepatitis in a Real-Life Setting: The HEPAVIR SEG-HEP Cohort.Comparative Clinical Pharmacokinetics and Pharmacodynamics of HIV-1 Integrase Strand Transfer Inhibitors.Combined Medication of Antiretroviral Drugs Tenofovir Disoproxil Fumarate, Emtricitabine, and Raltegravir Reduces Neural Progenitor Cell Proliferation In Vivo and In Vitro.
P2860
Plasma concentrations of efavirenz, darunavir/ritonavir and raltegravir in HIV-HCV-coinfected patients without liver cirrhosis in comparison with HIV-monoinfected patients.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Plasma concentrations of efavi ...... ith HIV-monoinfected patients.
@en
type
label
Plasma concentrations of efavi ...... ith HIV-monoinfected patients.
@en
prefLabel
Plasma concentrations of efavi ...... ith HIV-monoinfected patients.
@en
P2093
P2860
P1476
Plasma concentrations of efavi ...... ith HIV-monoinfected patients.
@en
P2093
Eleonora Magistrelli
Gabriella Verucchi
Ilaria Danese
Leonardo Calza
Pierluigi Viale
Roberto Manfredi
Roberto Motta
Vincenzo Colangeli
P2860
P304
P356
10.3109/23744235.2015.1034169
P50
P577
2015-04-15T00:00:00Z